Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC, explain how Mayo Clinic Laboratories' expanded test panel captures rarer as well as more common genetic causes of hereditary pancreatitis. That information is key to managing patients' enhanced risk for pancreatic cancer.

(00:32)
 Could you both please tell us a little bit about yourself and your background?

(02:23)
 Could you please give the audience a brief overview of this assay? 

(03:53)
 Which patients should have this test, and when should it be performed?

(04:49)
 What alternative testing options are available, and how do these compare to the new, expanded panel that we're going to be offering?

(08:20)

How are the results used in patient care?